Storia in 7 fonti

India approves Novo Nordisk’s weight loss drug Wegovy for fatty liver disease

The Central Drugs Standard Control Organization (CDSCO) has approved Danish major Novo Nordisk’s weight loss drug Wegovy (semaglutide injection 2.4 mg) for a new indication — fatty liver disease.

Raccontata da

valor.globo.com

benzinga.com

open.online

economictimes.indiatimes.com

thehindubusinessline.com

hindustantimes.com

thehindu.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

thehindu.comStai leggendo1 mese fa

India approves Novo Nordisk’s weight loss drug Wegovy for fatty liver disease

The Central Drugs Standard Control Organization (CDSCO) has approved Danish major Novo Nordisk’s weight loss drug Wegovy (semaglutide injection 2.4 mg) for a new indication — fatty liver disease.

originale

Timeline cronologica

mercoledì 15 luglio 2026·valor.globo.com
Novo Nordisk recebe aprovação da Comissão Europeia para Wegovy em comprimido
Com a aprovação, o medicamento passa a ser o primeiro com receptor GLP-1 disponível em formato oral para controle de peso na União Europeia (UE)
mercoledì 15 luglio 2026·benzinga.com
Wegovy Pill in Europe - Novo Nordisk Expands Franchise With First European Approval for Oral Weight Loss
Novo Nordisk wins EU approval for Wegovy pill, the first oral GLP-1 for weight management, backed by OASIS trial data.

India approves Novo Nordisk’s weight loss drug Wegovy for fatty liver disease

Confronto fonti

India approves Novo Nordisk’s weight loss drug Wegovy for fatty liver disease

Timeline cronologica

Novo Nordisk recebe aprovação da Comissão Europeia para Wegovy em comprimido

Wegovy Pill in Europe - Novo Nordisk Expands Franchise With First European Approval for Oral Weight Loss

Novo’s weight-loss drug Wegovy gets CDSCO approval for fatty liver disease

Novo Nordisk’s obesity drug Wegovy gets CDSCO approval to treat liver condition

Novo Nordisk's obesity drug Wegovy wins India approval to fight silent fatty liver killer

Wegovy Pill in Europe - Novo Nordisk Expands Franchise With First European Approval for Oral Weight Loss

Semaglutide in pillole, via libera dell’Ue al primo GLP-1 orale per la gestione del peso

Semaglutide in pillole, via libera dell’Ue al primo GLP-1 orale per la gestione del peso

Novo Nordisk's obesity drug Wegovy wins India approval to fight silent fatty liver killer

Novo Nordisk’s obesity drug Wegovy gets CDSCO approval to treat liver condition

Novo’s weight-loss drug Wegovy gets CDSCO approval for fatty liver disease

India approves Novo Nordisk’s weight loss drug Wegovy for fatty liver disease

Emcure's Poviztra gets CDSCO approval for fatty liver treatment

Emcure Pharma gets CDSCO nod to market Poviztra for fatty liver treatment